Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to demonstrate the clinical activity of nivolumab in combination with ipilimumab in multiple types of tumors based on their Tumor Mutational Burden status.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03668119
Study type Interventional
Source Bristol-Myers Squibb
Contact
Status Completed
Phase Phase 2
Start date October 31, 2018
Completion date August 2, 2023